Hugh Fryer
Rye, United States
331209 RESULTS
Rye, United States
University of KentuckyLecanto, United States
Univ. Lille, Inserm, U1171, CHU Lille, DISTALZLille, France
Uppsala UniversityUppsala, Sweden
Buenos Aires , Argentina
University of Massachusetts Medical SchoolUnited States
University of Louisiana at MonroeMonroe, United States
MUTATIONS PSEN2 227078994 GRCh37/hg19 rs144277432 C T Exon 10 Point, Missense Coding Unchanged Aβ42/Aβ40 ratio. Unknown. T301M Alzheimer's Disease: BenignAlzheimer's Disease This PSEN2 variant was reported in an individual from the Netherlands who died wi
FFULLisboa, Portugal
Shanghai Jiaotong University School of MedicineShanghai, China
Bristol-Myers SquibbDurham, United States
Nagasaki Uni.
RESEARCH NEWS 2013-12-13 Research News Many Alzheimer’s drugs that looked promising in animal and cell culture studies have failed in clinical trials. A paper in the December 17 Stem Cell Reports proposes a new explanation for one such class of drugs, namely γ-secretase modulator
Advanced Memory Dynamics Layton, United States
PAPER Bannwarth B, Netter P, Lapicque F, Péré P, Thomas P, Gaucher A
No filters selected